Legal & General Global Health & Pharmaceuticals Index Trust C Class Accumulation
Category Sector Equity Healthcare
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
82.20p
-0.51p (-0.62%)
Fund Code
LGHCA
BJ2JPG8
GB00BJ2JPG83
Prices updated as at 12 Nov 2024
Prices in GBX
Investment objective
The objective of the Fund is to track the performance of the FTSE World Index - Health Care (the “Benchmark Index”) on a net total return basis before fees and expenses are applied. Therefore, the Fund’s performance may differ from the Benchmark Index due to the deduction of fees and expenses and the impact of any tracking error factors. The Benchmark Index is comprised of shares in companies engaged in health, pharmaceuticals and biotechnology. The Fund is a Replicating Fund as it seeks to replicate as closely as possible the constituents of the Benchmark Index by holding all, or substantially all, of the assets comprising the Benchmark Index in similar proportions to their weightings in the Benchmark Index. The Fund will have at least 90% exposure to assets that are included in the Benchmark Index.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Fund status | Open |
Fund type | Unit Trust |
Fund manager | Not Disclosed |
86.75 | |
72.23 | |
Fund comparative index | FTSE World Health&Pharmaceutical PR GBP |
Healthcare | |
- | |
0.20 | |
0.12 | |
0.00 | |
Sector Equity Healthcare | |
No | |
Fund provider | Legal & General (Unit Trust Managers) Ltd |
Share class launch date | 22 Feb 2019 |
£1.25b | |
- | |
1.30 | |
- | |
- |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.